Financials

  • Market Capitalization 78.43 M
  • Employee 13
  • Founded 2018
  • CEO N/A
  • Website www.maiabiotech.com
  • Headquarter Delaware, United States
  • FIGI BBG0113Q7J88
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산

MAIA Biotechnology, Inc. Common Stock

MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells.

뉴스